Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Hjärt & kärl mottagningen i Malmö AB
AB
Bankrupt
Org 5593492977
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2021
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Hjärt & kärl mottagningen i Malmö AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
3M
5M
7M
2M
2022
6M
2023
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
Income statement
SEK thousands
Item
2022
2023
Revenue
1 577
5 738
Staff expenses
−215
−1 364
EBITDA
270
522
Depreciation & amort.
—
—
EBIT
270
522
Net financials
−0
−1
Profit before tax
198
389
Tax
−45
−82
Net profit
153
307
Balance sheet
SEK thousands
Item
2022
2023
Total assets
575
889
Equity
178
485
Long-term debt
—
8
Short-term debt
325
191
Total debt
325
199
Financial ratios
5-year trend
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
2022
2023
Equity ratio
54.5%
This company
38.2%
Market median
+43% vs market
2022
2023
Return on equity
63.3%
This company
18.4%
Market median
+244% vs market
2022
2023
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
2022
2023
Asset turnover
6.46×
This company
1.12×
Market median
+477% vs market
2022
2023
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
2022
2023
Annual reports & filings
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-11-29 – 2022-12-31
View
PDF
More on Hjärt & kärl mottagningen i Malmö AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
